North American bladder cancer market is estimated to grow significantly at a CAGR of around 9.6% during the forecast period. Major factors that are augmenting the growth of the North American bladder cancer market include increasing healthcare expenditure, raising awareness of cancer among the population, and surging aging population base coupled with the significant prevalence of bladder cancer across the region. Moreover, the presence of key market players in the region is also augmenting the market growth. Major players that are significantly present in the region are Pfizer, Inc., and Spectrum Pharmaceuticals, Inc.
Please read the originial post here: https://www.omrglobal.com/industry-reports/north-american-bladder-cancer-market